These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29309347)

  • 1. What is the risk of major congenital abnormalities among women on antiretroviral therapy?
    Zash RM; Williams P; Holmes LB
    AIDS; 2018 Jan; 32(3):403-404. PubMed ID: 29309347
    [No Abstract]   [Full Text] [Related]  

  • 2. Considerations on the potential teratogenic effects of antiretroviral therapy.
    Meli M; Vicidomini S; Bartoloni A
    Intern Emerg Med; 2006; 1(3):249-50. PubMed ID: 17120478
    [No Abstract]   [Full Text] [Related]  

  • 3. Preconception antiretroviral therapy and birth defects: what is needed?
    Bulterys M; Berry RJ; Watts DH
    AIDS; 2014 Nov; 28(18):2777-80. PubMed ID: 25493603
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiretroviral drug use during pregnancy and risk of premature delivery: is there a connection?
    Kourtis AP
    J Infect Dis; 2010 Apr; 201(7):978-80. PubMed ID: 20196653
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined antiretroviral therapy during pregnancy and risk of congenital malformations.
    Frieden IJ; Haggstrom AN; McCulloch C; Drolet B; Esterly NB; Garzon MC; Lucky AW; Baselga E; Friedlander SF
    JAMA; 2004 Apr; 291(16):1961-2; author reply 1962. PubMed ID: 15113813
    [No Abstract]   [Full Text] [Related]  

  • 6. Aggressive worsening of Sézary syndrome during early antiretroviral therapy.
    Lehloenya RJ; Shebe K; Hlela C; Dlamini S; Mankahla A; Lapiner V; Meintjes G; Todd G
    AIDS; 2013 Mar; 27(6):1035-1036. PubMed ID: 23698068
    [No Abstract]   [Full Text] [Related]  

  • 7. HIV, highly active antiretroviral therapy and the heart: a cellular to epidemiological review.
    Lambert CT; Sandesara PB; Hirsh B; Shaw LJ; Lewis W; Quyyumi AA; Schinazi RF; Post WS; Sperling L
    HIV Med; 2016 Jun; 17(6):411-24. PubMed ID: 26611380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in antiretroviral regimens do not impact safety or level of latency reversal in persons receiving romidepsin.
    Jørgensen S; Leth S; Sommerfelt M; Østergaard L; Tolstrup M; Søgaard OS
    AIDS; 2018 Jul; 32(12):1729-1731. PubMed ID: 30001247
    [No Abstract]   [Full Text] [Related]  

  • 9. Beginning antiretroviral therapy for patients with HIV.
    Johnson JA; Sax PE
    Infect Dis Clin North Am; 2014 Sep; 28(3):421-38. PubMed ID: 25151564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretroviral combination use during pregnancy and the risk of major congenital malformations.
    Bérard A; Sheehy O; Zhao JP; Abrahamowicz M; Loutfy M; Boucoiran I; Bernatsky S
    AIDS; 2017 Oct; 31(16):2267-2277. PubMed ID: 28806195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular risk and body-fat abnormalities in HIV-infected adults.
    Grinspoon S; Carr A
    N Engl J Med; 2005 Jan; 352(1):48-62. PubMed ID: 15635112
    [No Abstract]   [Full Text] [Related]  

  • 12. [Inappropriate combinations of antiretroviral drugs].
    Machala L; Cerný R
    Klin Mikrobiol Infekc Lek; 2004 Oct; 10(5):241-3. PubMed ID: 15558454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between atazanavir plasma levels and renal function in HIV-positive individuals on antiretroviral therapy with undetectable viral load.
    Luz AJ; Poeta J; Linden R; Antunes MV; Caminha LI; Callegari-Jacques SM; Sprinz E
    Int J Antimicrob Agents; 2013 May; 41(5):497-8. PubMed ID: 23453620
    [No Abstract]   [Full Text] [Related]  

  • 14. Adverse interactions with antiretroviral agents: focus on recreational and addiction drugs.
    Vassilev ZP; Marcus SM
    AIDS Read; 2004 Feb; 14(2):96. PubMed ID: 15083804
    [No Abstract]   [Full Text] [Related]  

  • 15. Does highly active antiretroviral therapy increase the risk of congenital abnormalities in HIV-infected women?
    Patel D; Thorne C; Fiore S; Newell ML;
    J Acquir Immune Defic Syndr; 2005 Sep; 40(1):116-8. PubMed ID: 16123696
    [No Abstract]   [Full Text] [Related]  

  • 16. Key Principles of Antiretroviral Pharmacology.
    Dionne B
    Infect Dis Clin North Am; 2019 Sep; 33(3):787-805. PubMed ID: 31395145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does antiretroviral therapy cause congenital malformations? A systematic review and meta-analysis.
    Alemu FM; Yalew AW
    Epidemiol Health; 2021; 43():e2021008. PubMed ID: 33541012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to anti-retroviral drugs.
    Roy MP
    Indian J Med Res; 2016 Feb; 143(2):245. PubMed ID: 27121524
    [No Abstract]   [Full Text] [Related]  

  • 19. Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants.
    Williams PL; Crain MJ; Yildirim C; Hazra R; Van Dyke RB; Rich K; Read JS; Stuard E; Rathore M; Mendez HA; Watts DH;
    JAMA Pediatr; 2015 Jan; 169(1):48-55. PubMed ID: 25383770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy.
    Alimenti A; Forbes JC; Oberlander TF; Money DM; Grunau RE; Papsdorf MP; Maan E; Cole LJ; Burdge DR
    Pediatrics; 2006 Oct; 118(4):e1139-45. PubMed ID: 16940166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.